tiprankstipranks
PolyPid announces DSMB recommendation to continue Phase 3 D-PLEX study
PremiumThe FlyPolyPid announces DSMB recommendation to continue Phase 3 D-PLEX study
1M ago
PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
Premium
Company Announcements
PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
2M ago
PolyPid announces research, development collaboration with ImmunoGenesis
Premium
The Fly
PolyPid announces research, development collaboration with ImmunoGenesis
2M ago
PolyPid reports Q3 EPS ($1.22), consensus ($1.00)
PremiumThe FlyPolyPid reports Q3 EPS ($1.22), consensus ($1.00)
3M ago
PolyPid sees runway into 1Q25
Premium
The Fly
PolyPid sees runway into 1Q25
3M ago
PYPD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PYPD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
PolyPid Nears Completion of Key Phase 3 Trial
PremiumCompany AnnouncementsPolyPid Nears Completion of Key Phase 3 Trial
4M ago
PolyPid enrolls last patient for planned unblinded interim analysis in SHIELD II
Premium
The Fly
PolyPid enrolls last patient for planned unblinded interim analysis in SHIELD II
4M ago
PolyPid files to sell 3.91M ordinary shares for holders
Premium
The Fly
PolyPid files to sell 3.91M ordinary shares for holders
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100